MX2014011838A - Uso de neuregulina para tratar lesion de nervio periferico. - Google Patents

Uso de neuregulina para tratar lesion de nervio periferico.

Info

Publication number
MX2014011838A
MX2014011838A MX2014011838A MX2014011838A MX2014011838A MX 2014011838 A MX2014011838 A MX 2014011838A MX 2014011838 A MX2014011838 A MX 2014011838A MX 2014011838 A MX2014011838 A MX 2014011838A MX 2014011838 A MX2014011838 A MX 2014011838A
Authority
MX
Mexico
Prior art keywords
peripheral nerve
nerve injury
neuregulin
treat peripheral
treat
Prior art date
Application number
MX2014011838A
Other languages
English (en)
Other versions
MX354598B (es
Inventor
Anthony O Caggiano
Anindita Ganguly
Jennifer Iaci
Anthony J Bella
Thomas Parry
Raymond Warren Colburn
Original Assignee
Acorda Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acorda Therapeutics Inc filed Critical Acorda Therapeutics Inc
Publication of MX2014011838A publication Critical patent/MX2014011838A/es
Publication of MX354598B publication Critical patent/MX354598B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1883—Neuregulins, e.g.. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La divulgación proporciona composiciones y métodos para prevenir, mejorar un signo o síntoma o tratar la lesión del nervio periférico.
MX2014011838A 2012-03-30 2013-03-29 Uso de neuregulina para tratar lesion de nervio periferico. MX354598B (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201261618381P 2012-03-30 2012-03-30
US201261674060P 2012-07-20 2012-07-20
US201261693585P 2012-08-27 2012-08-27
US201261693589P 2012-08-27 2012-08-27
US201361785419P 2013-03-14 2013-03-14
PCT/US2013/034634 WO2013149163A1 (en) 2012-03-30 2013-03-29 Use of neuregulin to treat peripheral nerve injury

Publications (2)

Publication Number Publication Date
MX2014011838A true MX2014011838A (es) 2015-03-09
MX354598B MX354598B (es) 2018-03-12

Family

ID=48128617

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014011838A MX354598B (es) 2012-03-30 2013-03-29 Uso de neuregulina para tratar lesion de nervio periferico.

Country Status (16)

Country Link
US (3) US20150094263A1 (es)
EP (3) EP3842059A1 (es)
JP (4) JP6420233B2 (es)
CN (2) CN104321072A (es)
AU (4) AU2013237896B2 (es)
BR (1) BR112014024308B1 (es)
CA (1) CA2869070A1 (es)
DK (2) DK3278811T3 (es)
ES (2) ES2857810T3 (es)
HK (2) HK1206632A1 (es)
IL (3) IL288785B2 (es)
MX (1) MX354598B (es)
NZ (1) NZ700546A (es)
PL (2) PL3278811T3 (es)
PT (2) PT2830645T (es)
WO (1) WO2013149163A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0916442A2 (pt) 2008-07-17 2018-06-19 Acorda Therapeutics, Inc. dosagem terapêutica de uma neuregulina ou de uma subsequência da mesma para tratamento ou profilaxia de insuficiência cardíaca
JP5832437B2 (ja) 2009-10-14 2015-12-16 アコーダ セラピューティクス インコーポレイテッド 末梢神経損傷を処置するためのニューレグリンの使用
ITUB20155471A1 (it) * 2015-11-11 2017-05-11 Univ Degli Studi Di Torino Coniugato della neuregulina 1 per il trattamento delle lesioni dei nervi periferici
IL294038A (en) * 2015-12-04 2022-08-01 Univ Iowa Res Found Device, systems and methods for prediction, screening and monitoring of encephalopathy / delirium
US11511136B2 (en) 2017-11-17 2022-11-29 The Research Foundation For The State University Of New York Method for treating damaged peripheral nerves using x-ray microbeam irradiation
CN110946991A (zh) * 2018-09-27 2020-04-03 广州中医药大学(广州中医药研究院) 神经调节蛋白1的应用
BR112022001518A2 (pt) * 2019-08-01 2022-05-03 Mark Evans Métodos para reduzir o risco de lesão neurológica e para identificar a existência de lesão neurológica, e, aparelho para reduzir o risco de lesão neurológica
CN116116737B (zh) * 2023-04-14 2023-06-30 新华手术器械有限公司 止血钳毛坯自动上料装置及使用方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7037A (en) 1850-01-22 Grid-ikon slide-valve
US888A (en) 1838-08-20 perkins
US5716930A (en) 1991-04-10 1998-02-10 Ludwig Institute For Cancer Research Glial growth factors
US5530109A (en) 1991-04-10 1996-06-25 Ludwig Institute For Cancer Research DNA encoding glial mitogenic factors
US7037888B1 (en) 1992-04-03 2006-05-02 Acorda Therapeutics, Inc. Methods for treating muscle diseases and disorders
US6087323A (en) * 1992-04-03 2000-07-11 Cambridge Neuroscience, Inc. Use of neuregulins as modulators of cellular communication
AU745324B2 (en) * 1997-10-14 2002-03-21 Cenes Pharmaceuticals, Inc. Therapeutic methods comprising use of a neuregulin
CA2808215A1 (en) * 2000-05-23 2001-11-29 Cenes Pharmaceuticals, Inc. Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
US20100286043A1 (en) * 2007-10-05 2010-11-11 Tufts Medical Center, Inc. Use of neuregulin-1 in reducing brain damage
WO2009108390A2 (en) * 2008-02-29 2009-09-03 Acorda Therapeutics, Inc. Method for achieving desired glial growth factor 2 plasma levels
BRPI0916442A2 (pt) * 2008-07-17 2018-06-19 Acorda Therapeutics, Inc. dosagem terapêutica de uma neuregulina ou de uma subsequência da mesma para tratamento ou profilaxia de insuficiência cardíaca
WO2010128807A2 (ko) * 2009-05-07 2010-11-11 (주)문엔제이 신경손상 및 신경질환 예방 또는 치료용 약학조성물
JP5832437B2 (ja) * 2009-10-14 2015-12-16 アコーダ セラピューティクス インコーポレイテッド 末梢神経損傷を処置するためのニューレグリンの使用
AU2011289218A1 (en) * 2010-08-13 2013-03-14 Georgetown University GGF2 and methods of use

Also Published As

Publication number Publication date
EP2830645B1 (en) 2017-08-30
JP6420233B2 (ja) 2018-11-07
US20160346353A1 (en) 2016-12-01
IL273186B (en) 2022-01-01
EP2830645A1 (en) 2015-02-04
JP2015514096A (ja) 2015-05-18
JP2021059605A (ja) 2021-04-15
ES2647917T3 (es) 2017-12-27
HK1206632A1 (en) 2016-01-15
CA2869070A1 (en) 2013-10-03
EP3842059A1 (en) 2021-06-30
IL273186A (en) 2020-04-30
PL2830645T3 (pl) 2018-01-31
AU2019202401A1 (en) 2019-05-02
AU2013237896B2 (en) 2017-11-02
PL3278811T3 (pl) 2021-08-02
AU2019202401B2 (en) 2020-10-15
US20150094263A1 (en) 2015-04-02
JP2017149746A (ja) 2017-08-31
EP3278811B1 (en) 2020-12-02
PT2830645T (pt) 2017-11-28
IL234882B (en) 2020-03-31
ES2857810T3 (es) 2021-09-29
MX354598B (es) 2018-03-12
HK1249038A1 (zh) 2018-10-26
AU2020260539A1 (en) 2020-11-26
BR112014024308A8 (pt) 2018-01-23
JP2019131582A (ja) 2019-08-08
DK2830645T3 (da) 2017-11-20
BR112014024308A2 (pt) 2017-08-08
AU2013237896A1 (en) 2014-10-16
IL234882A0 (en) 2014-12-31
PT3278811T (pt) 2021-03-03
IL288785B (en) 2022-11-01
CN104321072A (zh) 2015-01-28
IL288785A (en) 2022-02-01
JP7108724B2 (ja) 2022-07-28
BR112014024308B1 (pt) 2021-11-30
IL288785B2 (en) 2023-03-01
WO2013149163A1 (en) 2013-10-03
NZ700546A (en) 2017-05-26
US20230117985A1 (en) 2023-04-20
CN106511971A (zh) 2017-03-22
EP3278811A1 (en) 2018-02-07
DK3278811T3 (da) 2021-03-01
AU2018200592A1 (en) 2018-02-15

Similar Documents

Publication Publication Date Title
MX2014011838A (es) Uso de neuregulina para tratar lesion de nervio periferico.
MX359327B (es) Composiciones y sus usos para tratar y prevenir la enfermedad de huntington.
MX356525B (es) Vectores de virus asociados con adeno (aav) para uso en terapia de genes de coroideremia.
PH12015500525A1 (en) Formulations of enzalutamide
IN2015DN00438A (es)
CA2900335C (en) Synthetic analogs of epipolythiodioxopiperazines and uses thereof
WO2013177187A3 (en) Synergistic tumor treatment with extended-pk il-2 and therapeutic agents
IN2014DN09782A (es)
JO3343B1 (ar) أحماض 5- أمينوتتراهيدروكوينولين-2- كربوكسيليك جديدة واستخدامها
SG10201809290SA (en) Compositions and Methods to Treating Hemoglobinopathies
PH12015501983A1 (en) Peptides and compositions for treatment of joint damage
IN2014DN06792A (es)
MX2014008705A (es) Compuestos tricíclicos de sulfona y métodos para elaborarlos y utilizarlos.
MX356755B (es) Compuestos de tipo fumagilol y metodos para su elaboración y uso.
MX2012015305A (es) Compuestos heterociclicos, su preparacion y su aplicacion terapeutica.
TN2015000255A1 (fr) Chitine ou ses derives pour la prevention et/ou le traitement de parasitoses
MX2015005732A (es) Compuestos tricíclicos y métodos para hacer y utilizar los mismos.
MX2020009966A (es) Formas de dosificacion y usos terapeuticos de la l-4-cloro quinurenina.
MX348040B (es) Antagonistas de hedgehog que tienen residuos que se unen al zinc.
MX2015005733A (es) Compuestos triciclicos para usarse en el tratamiento y/o control de obesidad.
MX2016006544A (es) Witanolidos utiles para el tratamiento de enfermedades neurodegenerativas.
MX2015000804A (es) Composiciones y metodos para tratar el sarcoma de ewing y otros trastornos relacionados con ews-fli1.
MX362111B (es) Un metodo para mejorar la funcion hepatica.
IN2014KN01772A (es)
WO2012170664A3 (en) Methods of cancer treatment and prevention through the modulation of sirt4 activity

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration